Exploring the influence of particle shape and air velocity on the flowability in the respiratory tract: a computational fluid dynamics approach

被引:7
|
作者
Ali, Alaa M. [1 ]
Dena, Ahmed S. Abo [1 ,2 ]
Yacoub, Magdi H. [3 ]
El-Sherbiny, Ibrahim M. [1 ]
机构
[1] Zewail City Sci & Technol, Nanomed Lab, Ctr Mat Sci, Giza 12578, Egypt
[2] NODCAR, Pharmaceut Chem Dept, Giza, Egypt
[3] Imperial Coll, Harefield Heart Sci Ctr, Natl Heart & Lung Inst, London, England
关键词
Dry powder inhalers; flowability; computational fluid dynamics; particle shape; COMSOL; drag force; DELIVERY; SIZE;
D O I
10.1080/03639045.2019.1600534
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Dry powder inhalers (DPIs) are considered a main drug delivery system through pulmonary route. The main objective of this work is to study the flow of differently shaped microparticles in order to find the optimum shape of drug particles that will demonstrate the best flow to the deep lung. The flowability of particles in air or any fluid depends particularly on the drag force which is defined as the resistance of the fluid molecules to the particle flow. One of the most important parameters that affect the drag force is the particles' shape. Computational simulations using COMSOL Multi Physics 5.2 software were performed for investigating the particles flow in the air pathways of lung, and the drag force was calculated for different particles shapes. This was accomplished by screening a set of 17 possible shapes that are expected to be synthesized easily in the micro-scale. In addition, the macro-scale behavior of the investigated shapes was also simulated so as to compare the behavior of the flowing particles in both cases. A very big difference was found between the behavior of particles' flow in the micro and macro scales, but a similar behavior can be obtained if the flow velocity of the microparticles is very high. It was also found that the micro-triangle with aspect ratio 2:1 has the least drag force in both deep and upper lung; so, it should be the shape of choice during the process of particle synthesis for pulmonary drug delivery.
引用
收藏
页码:1149 / 1156
页数:8
相关论文
共 50 条